Abstract
The aim of this paper is to describe the technique of percutaneous ultrasound (US)-guided placement of a peritoneal port-catheter in an interventional radiological setting. Nineteen patients with peritoneal carcinomatosis were selected for intraperitoneal port-catheter placement in order to perform intracavitary receptor-immuno- or radio-immunotherapy with Ytrium-90. All the procedures were performed percutaneously under US and fluoro guidance; the insertion site for catheters was chosen according to abdominal conditions and US findings: all devices were implanted at the lower abdominal quadrants. All patients were followed up with CT and US according to the therapy protocol. The procedure was successfully completed in 15/19 patients, in 4 being contraindicated by peritoneal adhesions. No procedure-related complications and device occlusions during therapy were observed; one catheter displaced 7 months later the placement. In our experience, this procedure was feasible, reliable and easy to perform, allowing the correct administration of the planned intracavitary therapy. Peritoneal adhesions are the main limitation of peritoneal port placement.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Markman M (1986) Intraperitoneal antineoplastic agents for tumors principally confined to the peritoneal cavity. Cancer Treat Rev 13:219–242
Los G, Mc Vie GJ (1990) Experimental and clinical status of intraperitoneal chemotherapy. Eur J Cancer 26:755–762
Alberts DS, Liu PY, Hannigan EV et al (1996) Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus cyclophosphamide for stage III ovarian cancer. N Engl J Med 335:1950–1955
Paganelli G, Belloni C, Magnani P, Zito F, Pasini A et al (1992) Two-step tumour targetting in ovarian cancer patients using biotinylated monoclonal antibodies and radioactive streptavidin. Eur J Nucl Med 19:322–329
Jenkins J, Sugarbaker PH, Gianola FJ et al (1982) Technical considerations in the use of intraperitoneal chemotherapy administered by Tenckhoff catheter. Surg Gynecol Obstet 154:858–864
Waggoner SE, Johnson J, Barter J et al (1994) Intraperitoneal therapy administered through a Groshong catheter. Gynecol Oncol 53:320–325
Malmstrom H, Cartensen J, Simonsen E (1994) Experience with implanted subcutaneous ports for intraperitoneal chemotherapy in ovarian cancer. Gynecol Oncol 54:27–34
Pleiffer P, Asmussen L, Kvist-Poulsen HY et al (1989) Intraperitoneal chemotherapy: introduction of a new “single-use” delivery system—a preliminary report. Gynecol Oncol 35:47–49
Almadores L, Yerys C (1990) Problems associated with the administration of intraperitoneal therapy using Porth-A Cath system. Oncol Nurs Forum 17(1):75–80
Braly P, Doroshow J, Hoff S (1986) Technical aspects of intraperitoneal chemotherapy in abdominal carcinomatosis. Gynecol Oncol 25:319–333
Laffer U, Durig M, Bloch HR et al (1989) Implatierbarte Katheter-systeme-Erfahrungen bei 205 Patienten. Dtsch Med Wochenschr 114:655–658
Topuz E, Salihoglu Y, Aydiner A et al (2000) Celsite® Port and Catheter as an intraperitoneal access device in the treatment of ovarian cancer. J Surg Oncol 74:223–226
Biffi R, De Braud F, Orsi F, Pozzi S et al (2001) A randomized, prospective trial of central venous ports connected to standard open-ended or Groshong catheters in adult oncology patients. Cancer 92:1204–1212
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Orsi, F., Vigna, P.D., Penco, S. et al. Percutaneous placement of peritoneal port-catheter in oncologic patients. Eur Radiol 14, 2020–2024 (2004). https://doi.org/10.1007/s00330-004-2367-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-004-2367-4